NDC product
Cetaphil Eczema Flare-Up Cream
NDC 0299-4139 · Galderma Laboratories, L.P.
Key facts
| Product NDC | 0299-4139 |
|---|---|
| Proprietary name | Cetaphil Eczema Flare-Up Cream |
| Labeler | Galderma Laboratories, L.P. |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M016 |
| Marketing start | Feb 1, 2023 |
| Marketing end | Nov 24, 2025 |
| Listing certified through | Nov 24, 2025 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: